Indomethacin tocolysis and neurodevelopmental outcome

Indian Journal of Pediatrics

Volumn 78, Issue 8, 2011, Pages 946-952

  Soraisham, Amuchou S ^a,b   Sauve, Reg ^a   Singhal, Nalini ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Indomethacin; Neurodevelopment; Outcome; Premature; Tocolysis

Indexed keywords

INDOMETACIN;

ARTICLE; BIRTH WEIGHT; BLINDNESS; CEREBRAL PALSY; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HEARING IMPAIRMENT; HUMAN; INCIDENCE; INFANT; LOADING DRUG DOSE; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; NEUROLOGIC EXAMINATION; PATENT DUCTUS ARTERIOSUS; PHYSICAL EXAMINATION; PRENATAL DRUG EXPOSURE; RETROSPECTIVE STUDY; TOCOLYSIS;

ADULT; CHILD, PRESCHOOL; COHORT STUDIES; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; INDOMETHACIN; MALE; MATERNAL-FETAL EXCHANGE; NERVOUS SYSTEM DISEASES; PREGNANCY; RETROSPECTIVE STUDIES; TOCOLYSIS; TOCOLYTIC AGENTS;

EID: 79961172901     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-011-0365-5     Document Type: Article

References (25)

1. M Hack AA Fanaroff 1999 Outcomes of children of extremely low birth weight and gestational age in the 1990's Early Hum Dev 53 193 218 10088988 10.1016/S0378-3782(98)00052-8 1:STN:280:DyaK1M7os1ynuw%3D%3D (Pubitemid 28556879)
2. H Zuckerman U Reiss I Rubinstein 1974 Inhibition of human premature labor by indomethacin Obstet Gynecol 44 787 92 4437814 1:STN:280: DyaE2M%2FmsVGqtg%3D%3D
3. KR Panter ME Hannah KS Amankwah A Ohlsson AL Jefferies D Farine 1999 The effect of indomethacin tocolysis in preterm labour on perinatal outcome: a randomised placebo-controlled trial Br J Obstet Gynaecol 106 467 73 10430197 10.1111/j.1471-0528.1999.tb08300.x 1:CAS:528:DyaK1MXjsVGns7s%3D (Pubitemid 29201527)
4. D Roberts S Dalziel 2006 Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth Cochrane Database Syst Rev 3 CD004454 16856047 1:STN:280:DC%2BD28vivFehuw%3D%3D
5. ME Norton J Merrill BA Cooper JA Kuller RI Clyman 1993 Neonatal complications after the administration of indomethacin for preterm labor New Engl J Med 329 1602 7 8232428 10.1056/NEJM199311253292202 1:STN:280: DyaK2c%2FkvF2qtQ%3D%3D (Pubitemid 23345638)
6. VR Suarez LL Thompson V Jain, et al. 2002 The effect of in utero exposure to indomethacin on the need for surgical closure of a patent ductus arteriosus in the neonate Am J Obstet Gynecol 187 886 8 12388970 10.1067/mob.2002.127464 1:CAS:528:DC%2BD38XovVCktLw%3D (Pubitemid 35178376)
7. AS Soraisham S Dalgleish N Singhal 2010 Antenatal indomethacin tocolysis is associated with an increased need for surgical ligation of patent ductus arteriosus in preterm infants J Obstet Gynaecol Can 32 435 42 20500951
8. SB Amin RA Sinkin JC Glantz 2007 Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes Am J Obstet Gynecol 197 486.e1 10 10.1016/j.ajog.2007.04.019 (Pubitemid 350007385)
9. CW Leffler DW Busija AM Fletcher DG Beasley JR Hessler RS Green 1985 Effects of indomethacin upon cerebral hemodynamics of newborn pigs Pediatr Res 19 1160 4 4069824 10.1203/00006450-198511000-00009 1:CAS:528:DyaL2MXmtVKjt7o%3D (Pubitemid 16257010)
10. JC Madan D Kendrick JI Hagadorn ID Frantz 3rd 2009 Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome Pediatrics 123 674 81 19171637 10.1542/peds.2007-2781
11. NS Kabra B Schmidt RS Roberts LW Doyle L Papile A Fanaroff 2007 Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms J Pediatr 150 229 34 17307535 10.1016/j.jpeds.2006.11. 039 1:CAS:528:DC%2BD2sXhvVGls74%3D (Pubitemid 46343549)
12. WM Gersony GJ Peckham RC Ellison OS Miettinen A Nadas 1983 Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study J Pediatr 102 895 906 6343572 10.1016/S0022- 3476(83)80022-5 1:STN:280:DyaL3s3hsFKisw%3D%3D (Pubitemid 13058794)
13. JL Grosfeld M Chaet F Molinari, et al. 1996 Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin Ann Surg 224 350 5 8813263 10.1097/00000658-199609000-00011 1:STN:280:DyaK28vgvVaiug%3D%3D (Pubitemid 26307477)
14. AS Soraisham HJ Amin MY Al-Hindi N Singhal RS Sauve 2006 Does necrotising enterocolitis impact the neurodevelopmental and growth outcomes in preterm infants with birthweight ≤ 1250 g? J Paediatr Child Health 42 499 504 16925534 10.1111/j.1440-1754.2006.00910.x (Pubitemid 44252519)
15. SM Schulzke GC Deshpande SK Patole 2007 Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies Arch Pediatr Adolesc Med 161 583 90 17548764 10.1001/archpedi.161.6.583 (Pubitemid 46878688)
16. JM Perlman 1998 White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome Early Hum Dev 53 99 120 10195704 10.1016/S0378-3782(98)00037-1 1:STN:280:DyaK1M3htVSkuw%3D%3D (Pubitemid 28517940)
17. CE Mercier MS Dunn KR Ferrelli DB Howard RF Soll 2010 Neurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford network: 1998-2003 Neonatology 97 329 38 19940516 10.1159/000260136
18. S Al-Alaiyan MM Seshia OG Casiro 1996 Neurodevelopmental outcome of infants exposed to indomethacin antenatally J Perinat Med 24 405 11 8880639 10.1515/jpme.1996.24.4.405 1:STN:280:DyaK2s%2FjsV2rsQ%3D%3D (Pubitemid 26278829)
19. T Salokorpi M Eronen L von Wendt 1996 Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin Neuropediatrics 27 174 7 8892364 10.1055/s-2007-973782 1:STN:280: DyaK2s%2FkslCntg%3D%3D (Pubitemid 26319249)
20. SB Amin M Kamaluddeen M Sangem 2008 Neurodevelopmental outcome of premature infants after exposure to antenatal indomethacin Am J Obstet Gynecol 199 41.e1 8 10.1016/j.ajog.2007.12.037
21. RI Clyman YQ Chen S Chemtob, et al. 2001 In utero remodelling of the lamb ductus arteriosus: the role of antenatal indomethacin and avascular zone thickness in vasa vasorum proliferation, neointima formation, and cell death Circulation 103 1806 12 11282914 1:CAS:528:DC%2BD3MXjsFKisbo%3D (Pubitemid 32291420)
22. LR Ment B Vohr W Oh, et al. 1996 Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the multicenter indomethacin intraventricular hemorrhage prevention trial Pediatrics 98 714 8 8885951 1:STN:280:DyaK2s%2FktVKgug%3D%3D
23. B Schmidt P Davis D Moddemann, et al. 2001 Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants N Engl J Med 344 1966 72 11430325 10.1056/NEJM200106283442602 1:CAS:528:DC%2BD3MXltFers74%3D (Pubitemid 32568150)
24. MM Costantine SJ Weiner 2009 Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis Obstet Gynecol 114 354 64 19622997 10.1097/AOG.0b013e3181ae98c2
25. Magpie Trial Follow-Up Study Collaborative Group 2007 The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months BJOG 114 289 99